Franklin Genomic Advancements ETF · $36M$8,473
HELXHELX vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 26.4% in common
HELXMeasureARKG
Returns · dividends reinvested
+22.4%Year to dateJan 1 → Nov 3+70.9%
+26.6%1 yearTotal return+59.0%
+20.5%3 years · per year$10,000 became $17,514 · $22,262+30.6%
−3.3%5 years · per year$10,000 became $8,473 · $6,586−8.0%
Cost and income
0.50%Expense ratio$50 · $75 a year on $10k · lower is better0.75%
0.32%Trailing 12-mo yield$32 · $0 a year on $10k0.00%
Risk · past year
−18.0%Worst dropSmaller is better−27.5%
24.6%VolatilityLower is calmer45.8%
HELXARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3HELX wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns